Financials Allmed Solutions Ltd
Equities
ALMD
IL0011014508
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.8 ILa | 0.00% |
|
0.00% | -9.14% |
03-07 | Allmed Solutions Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-05 | Allmed Solutions Ltd announces an Equity Buyback for $1.5 million worth of its shares. | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 44.63 | 39.76 | 43.05 | 35.4 | 20.12 | 40.22 |
Enterprise Value (EV) 1 | 27.87 | 22.79 | 35.27 | 20.15 | -0.2395 | -16.01 |
P/E ratio | -2.01 x | 1.8 x | -4.87 x | 14.6 x | -1.78 x | 28.3 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 4.81 x | 3.57 x | 4.43 x | 6.38 x | - | - |
EV / Revenue | 3 x | 2.04 x | 3.63 x | 3.63 x | - | - |
EV / EBITDA | -1.31 x | -1.31 x | -3.84 x | -2.4 x | 0.02 x | 1.5 x |
EV / FCF | -2.09 x | -1.15 x | -6.14 x | 0.77 x | 0.03 x | -0.7 x |
FCF Yield | -47.8% | -86.9% | -16.3% | 129% | 3,530% | -144% |
Price to Book | 1.36 x | 0.69 x | 0.88 x | 0.7 x | 0.52 x | 0.76 x |
Nbr of stocks (in thousands) | 79,841 | 80,316 | 80,316 | 80,821 | 80,821 | 108,110 |
Reference price 2 | 0.5590 | 0.4950 | 0.5360 | 0.4380 | 0.2490 | 0.3720 |
Announcement Date | 10/03/19 | 12/03/20 | 15/03/21 | 24/02/22 | 16/03/23 | 07/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 9.279 | 11.15 | 9.719 | 5.545 | - | - |
EBITDA 1 | -21.27 | -17.45 | -9.194 | -8.406 | -12.31 | -10.7 |
EBIT 1 | -23.21 | -18.77 | -9.805 | -8.958 | -12.41 | -10.85 |
Operating Margin | -250.18% | -168.37% | -100.88% | -161.55% | - | - |
Earnings before Tax (EBT) 1 | -20.48 | 21.38 | -9.249 | 2.703 | -12.14 | 1.422 |
Net income 1 | -20.18 | 21.99 | -8.658 | 2.808 | -12.14 | 1.422 |
Net margin | -217.43% | 197.25% | -89.08% | 50.64% | - | - |
EPS 2 | -0.2778 | 0.2744 | -0.1100 | 0.0300 | -0.1400 | 0.0131 |
Free Cash Flow 1 | -13.33 | -19.79 | -5.74 | 26.03 | -8.455 | 23.02 |
FCF margin | -143.71% | -177.55% | -59.06% | 469.44% | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | 927% | - | 1,618.98% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 10/03/19 | 12/03/20 | 15/03/21 | 24/02/22 | 16/03/23 | 07/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 16.8 | 17 | 7.78 | 15.3 | 20.4 | 56.2 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -13.3 | -19.8 | -5.74 | 26 | -8.46 | 23 |
ROE (net income / shareholders' equity) | -57.2% | 47.8% | -17.6% | 5.35% | -22.8% | 2.59% |
ROA (Net income/ Total Assets) | -30.6% | -21.3% | -9.92% | -10.1% | -13.8% | -11.6% |
Assets 1 | 66.01 | -103.4 | 87.29 | -27.87 | 88.12 | -12.26 |
Book Value Per Share 2 | 0.4100 | 0.7100 | 0.6100 | 0.6200 | 0.4800 | 0.4900 |
Cash Flow per Share 2 | 0.1000 | 0.1800 | 0.1200 | 0.1900 | 0.1900 | 0.0600 |
Capex 1 | 0.19 | 0.08 | 0.13 | 0.04 | 0.44 | 0.12 |
Capex / Sales | 2.07% | 0.7% | 1.34% | 0.79% | - | - |
Announcement Date | 10/03/19 | 12/03/20 | 15/03/21 | 24/02/22 | 16/03/23 | 07/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-9.14% | 8.65M | |
+11.63% | 128B | |
-9.78% | 10.75B | |
-18.88% | 7.19B | |
+49.68% | 6.41B | |
-34.01% | 4.12B | |
+8.39% | 3.43B | |
-20.19% | 2.43B | |
-19.41% | 1.9B | |
-20.90% | 1.66B |
- Stock Market
- Equities
- ALMD Stock
- Financials Allmed Solutions Ltd